Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Price Concessions By Manufacturers To Payers Rose Sharply In 2015

This article was originally published in The Pink Sheet Daily

Executive Summary

Net spending on all drugs rose 8.5% to $310bn in the US in 2015 when discounts, rebates and other price concessions are considered, annual IMS review says.

Advertisement

Related Content

US Branded Drug Invoice Price Increases Moderate In 2016
US Branded Drug Invoice Price Increases Moderate In 2016
Drug Pricing: PhRMA Report Aims To Shift Focus To Supply Chain
Pharma's Middlemen Get Fatter: PBM, Health Plan Rebates Near $58bn
Gap Between Invoice And Real Prices Widening, QuintilesIMS Says
US Retail Drug Spending Growth Slowing With No New Sovaldis In Sight

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS079315

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel